Ventas (NYSE:VTR) Upgraded by Raymond James Financial to “Moderate Buy” Rating

Raymond James Financial upgraded shares of Ventas (NYSE:VTR) to a moderate buy rating in a research note released on Tuesday morning,Zacks.com reports.

A number of other brokerages have also weighed in on VTR. Wells Fargo & Company boosted their target price on shares of Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Evercore reaffirmed an “outperform” rating and issued a $95.00 target price on shares of Ventas in a report on Wednesday, April 29th. KeyCorp increased their price objective on shares of Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Mizuho set a $98.00 price objective on shares of Ventas in a report on Friday, May 22nd. Finally, JPMorgan Chase & Co. increased their price target on shares of Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Monday, May 11th. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Ventas currently has an average rating of “Moderate Buy” and a consensus target price of $96.41.

Ventas Stock Performance

VTR stock opened at $82.21 on Tuesday. The stock has a market capitalization of $39.97 billion, a PE ratio of 149.48, a price-to-earnings-growth ratio of 1.80 and a beta of 0.71. Ventas has a 12-month low of $61.76 and a 12-month high of $91.06. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The stock’s 50 day simple moving average is $85.15 and its 200 day simple moving average is $82.58.

Ventas (NYSE:VTR) last released its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business’s revenue was up 22.0% compared to the same quarter last year. During the same period last year, the company posted $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, research analysts forecast that Ventas will post 3.88 earnings per share for the current fiscal year.

Ventas Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Ventas’s dividend payout ratio (DPR) is 378.18%.

Insider Activity at Ventas

In other Ventas news, Director Michael J. Embler acquired 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were bought at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the acquisition, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. This represents a 14.97% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the sale, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.53% of the company’s stock.

Institutional Investors Weigh In On Ventas

Several institutional investors have recently bought and sold shares of the company. Dynamic Wealth Strategies LLC acquired a new stake in shares of Ventas during the first quarter worth $25,000. GoalVest Advisory LLC purchased a new position in shares of Ventas during the fourth quarter worth $26,000. Wiser Advisor Group LLC purchased a new position in shares of Ventas during the third quarter worth $27,000. IFC & Insurance Marketing Inc. purchased a new position in Ventas in the fourth quarter valued at $30,000. Finally, Elyxium Wealth LLC purchased a new position in Ventas in the fourth quarter valued at $33,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.